menu search

Li-cycle alert: bragar eagel & squire, p.c. is investigating li-cycle, corp. on behalf of li-cycle stockholders and encourages investors to contact the firm

NEW YORK, Nov. 03, 2023 (GLOBE NEWSWIRE) — Bragar Eagel & Squire, P.C., a nationally recognized stock...

November 4, 2023, 1:00 am

Dollar alert: bragar eagel & squire, p.c. is investigating dollar general corporation on behalf of dollar stockholders and encourages investors to contact the firm

NEW YORK, Nov. 03, 2023 (GLOBE NEWSWIRE) — Bragar Eagel & Squire, P.C., a nationally recognized stock...

November 4, 2023, 1:00 am

Docgo alert: bragar eagel & squire, p.c. reminds investors that a class action lawsuit has been filed against docgo, inc. and encourages investors to contact the firm

NEW YORK, Nov. 03, 2023 (GLOBE NEWSWIRE) — Bragar Eagel & Squire, P.C., a nationally recognized stock...

November 4, 2023, 1:00 am

R1 rcm alert: bragar eagel & squire, p.c. is investigating r1 rcm corp. on behalf of r1 rcm stockholders and encourages investors to contact the firm

NEW YORK, Nov. 03, 2023 (GLOBE NEWSWIRE) — Bragar Eagel & Squire, P.C., a nationally recognized stock...

November 4, 2023, 1:00 am

Path final deadline: rosen, national trial lawyers, encourages uipath, inc. investors to secure counsel before important deadline in securities class action – path

NEW YORK, Nov. 03, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, re...

November 4, 2023, 1:00 am

Latest bitcoin price data suggests double top above $200k in 2025 – cointelegraph

Bitcoin halving cycles still dictate potential BTC price highs and lows, DecenTrader co-founder Filbfilb says, as he doubles down on $180,000 in ...

November 4, 2023, 12:44 am

Fairfax financial: q3 2023 results indicate banner year ahead

YTD book value per share increased 16.4% before dividends and 15% ex-dividends. YTD gross premiums written up 7.5% with a combined ratio of ~94%. Mana...

November 4, 2023, 12:42 am

Rosen, a leading law firm, encourages pacwest bancorp investors with losses in excess of $100k to secure counsel before important deadline in securities class action – pacw, pacwp

NEW YORK, Nov. 03, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, re...

November 4, 2023, 12:30 am

Investors sue barclays for inaccurately disclosing ex-ceo’s ties to jeffrey epstein – hagens berman

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Barclays PLC (BCS) Investors with Substantial Losses to Contact Firm’s Attorneys, Securities Fra...

November 4, 2023, 12:22 am

U.s. ipo weekly recap: biotech lexeo stumbles after $100 million ipo

Two IPOs are currently scheduled for the week ahead, although some small issuers may join the calendar late. As of 11/2/...

November 4, 2023, 12:21 am

Seacor marine: good company, but not good enough

The OSV market is expected to face a deficit due to low order book levels and declining shipyard capacity, but growing demand from deep-water protects...

November 4, 2023, 12:05 am

South korea's exports rebound in october 2023

South Korea's exports to mainland China have remained weak during 2023, recording a decline of 9.5% y/y...

November 4, 2023, 12:04 am

Summary 11/6 – 11/10

Monday, Nov 6, 2023 Tuesday, Nov 7, 2023 Wednesday, Nov ...

November 4, 2023, 12:00 am

Rosen, top ranked investor counsel, encourages tandem diabetes care, inc. investors to secure counsel before important deadline in securities class action – tndm

NEW YORK, Nov. 03, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, re...

November 4, 2023, 12:00 am

Regal rexnord corporation (rrx) q3 2023 earnings call transcript

Regal Rexnord Corporation (NYSE:RRX ) Q3 2023 Earnings Conference Call November 2, ...

November 3, 2023, 11:54 pm

Egain corporation (egan) q1 2024 earnings call transcript

eGain Corporation (NASDAQ:EGAN ) Q1 2024 Earnings Conference Call November 2, ...

November 3, 2023, 11:30 pm

Replimune presents updated interim results from the artacus clinical trial of rp1 monotherapy in solid organ and hematopoietic cell transplant recipients with skin cancers during oral presentation at

RP1 as monotherapy showed clear anti-tumor activity with an overall response rate of nearly 35 percent in evaluable patients WOBURN, Mass., Nov. 03, <...

November 3, 2023, 11:30 pm

Replimune presents updated interim results from the artacus clinical trial of rp1 monotherapy in solid organ and hematopoietic cell transplant recipients with skin cancers during oral presentation at

RP1 as monotherapy showed clear anti-tumor activity with an overall response rate of nearly 35 percent in evaluable patients WOBURN, Mass., Nov. 03, <...

November 3, 2023, 11:30 pm

Replimune presents updated interim results from the artacus clinical trial of rp1 monotherapy in solid organ and hematopoietic cell transplant recipients with skin cancers during oral presentation at

RP1 as monotherapy showed clear anti-tumor activity with an overall response rate of nearly 35 percent in evaluable patients WOBURN, Mass., Nov. 03, <...

November 3, 2023, 11:30 pm


Search within

Pages Search Results: